BGMS 8-K 2026-11-12

Bio Green Med Solution, Inc. (BGMS) 8-K dated 2026-11-12 — accession 0001493152-26-051465.

Bio Green Med Solution, Inc. (BGMS) common stock.

Bio Green Med Solution, Inc. filed a 8-K on 2026-11-12. Accession 0001493152-26-051465.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BGMS revenue for 2025-12-31 was $0. Net income was -$3.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. BGMS currently screens at market cap $4.7M.

Not investment advice. The BGMS SEC hub lists recent forms. The stock page is the research view.